1-13 of 13
Donald J. Buchsbaum
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract POSTER-THER-1402: Overcoming platinum resistance in ovarian cancer with niclosamide

Rebecca C. Arend, MD, Abhishek Gangrade, Christen L. Walters Haygood, MD, Chandrika Kurpad, Brandon J. Metge, Rajeev S. Samant, PhD, Pui-Kai Li, PhD, Yonghe Li, PhD, Deepak Bhasin, PhD, Charles Landen, MD, Ronald Alvarez, MD, J. Michael Straughn, MD, Donald J. Buchsbaum, PhD
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (16_Supplement): POSTER-THER-1402.
https://doi.org/10.1158/1557-3265.OVCASYMP14-POSTER-THER-1402
Published: 15 August 2015
View articletitled, Abstract POSTER-THER-1402: Overcoming platinum resistance in ovarian cancer with niclosamide
Journal Articles

Anti-EMMPRIN Monoclonal Antibody as a Novel Agent for Therapy of Head and Neck Cancer

Nichole R. Dean, J. Robert Newman, Emily E. Helman, Wenyue Zhang, Seena Safavy, D.M. Weeks, Mark Cunningham, Linda A. Snyder, Yi Tang, Li Yan, Lacey R. McNally, Donald J. Buchsbaum, Eben L. Rosenthal
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (12): 4058–4065.
https://doi.org/10.1158/1078-0432.CCR-09-0212
Published: 15 June 2009
View articletitled, Anti-EMMPRIN Monoclonal Antibody as a Novel Agent for Therapy of Head and Neck Cancer
Open the PDF for Anti-EMMPRIN Monoclonal Antibody as a Novel Agent for Therapy of Head and Neck Cancer in another window
Journal Articles

Treatment of Human Colon Cancer Xenografts with TRA-8 Anti-death Receptor 5 Antibody Alone or in Combination with CPT-11

Patsy G. Oliver, Albert F. LoBuglio, Kurt R. Zinn, Hyunki Kim, Li Nan, Tong Zhou, Wenquan Wang, Donald J. Buchsbaum
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (7): 2180–2189.
https://doi.org/10.1158/1078-0432.CCR-07-1392
Published: 01 April 2008
View articletitled, Treatment of Human Colon Cancer Xenografts with TRA-8 Anti-death Receptor 5 Antibody Alone or in Combination with CPT-11
Open the PDF for Treatment of Human Colon Cancer Xenografts with TRA-8 Anti-death Receptor 5 Antibody Alone or in Combination with CPT-11 in another window
Includes: Supplementary data
Journal Articles

Combination Treatment with TRA-8 Anti–Death Receptor 5 Antibody and CPT-11 Induces Tumor Regression in an Orthotopic Model of Pancreatic Cancer

Leo Christopher DeRosier, Donald J. Buchsbaum, Patsy G. Oliver, Zhi-Qiang Huang, Jeffrey C. Sellers, William E. Grizzle, Wenquan Wang, Tong Zhou, Kurt R. Zinn, Joshua W. Long, Selwyn M. Vickers
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (18): 5535s–5543s.
https://doi.org/10.1158/1078-0432.CCR-07-1075
Published: 17 September 2007
View articletitled, Combination Treatment with TRA-8 Anti–Death Receptor 5 Antibody and CPT-11 Induces Tumor Regression in an Orthotopic Model of Pancreatic Cancer
Open the PDF for Combination Treatment with TRA-8 Anti–Death Receptor 5 Antibody and CPT-11 Induces Tumor Regression in an Orthotopic Model of Pancreatic Cancer in another window
Journal Articles

Brief Overview of Preclinical and Clinical Studies in the Development of Intraperitoneal Radioimmunotherapy for Ovarian Cancer

Ruby F. Meredith, Donald J. Buchsbaum, Ronald D. Alvarez, Albert F. LoBuglio
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (18): 5643s–5645s.
https://doi.org/10.1158/1078-0432.CCR-07-0985
Published: 17 September 2007
View articletitled, Brief Overview of Preclinical and Clinical Studies in the Development of Intraperitoneal Radioimmunotherapy for Ovarian Cancer
Open the PDF for Brief Overview of Preclinical and Clinical Studies in the Development of Intraperitoneal Radioimmunotherapy for Ovarian Cancer in another window
Journal Articles

Antitumor Efficacy of Capecitabine and Celecoxib in Irradiated and Lead-Shielded, Contralateral Human BxPC-3 Pancreatic Cancer Xenografts: Clinical Implications of Abscopal Effects

Carmelo Blanquicett, M. Wasif Saif, Donald J. Buchsbaum, Mohamad Eloubeidi, Selwyn M. Vickers, David C. Chhieng, Mark D. Carpenter, Jeffrey C. Sellers, Suzanne Russo, Robert B. Diasio, Martin R. Johnson
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (24): 8773–8781.
https://doi.org/10.1158/1078-0432.CCR-05-0627
Published: 16 December 2005
View articletitled, Antitumor Efficacy of Capecitabine and Celecoxib in Irradiated and Lead-Shielded, Contralateral Human BxPC-3 Pancreatic Cancer Xenografts: Clinical Implications of Abscopal Effects
Open the PDF for Antitumor Efficacy of Capecitabine and Celecoxib in Irradiated and Lead-Shielded, Contralateral Human BxPC-3 Pancreatic Cancer Xenografts: Clinical Implications of Abscopal Effects in another window
Journal Articles

Intraperitoneal Pretarget Radioimmunotherapy with CC49 Fusion Protein

Donald J. Buchsbaum, M.B. Khazaeli, Donald B. Axworthy, Jody Schultz, Tandra R. Chaudhuri, Kurt R. Zinn, Mark Carpenter, Albert F. LoBuglio
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (22): 8180–8185.
https://doi.org/10.1158/1078-0432.CCR-05-0607
Published: 18 November 2005
View articletitled, Intraperitoneal Pretarget Radioimmunotherapy with CC49 Fusion Protein
Open the PDF for Intraperitoneal Pretarget Radioimmunotherapy with CC49 Fusion Protein in another window
Journal Articles

Antitumor Efficacy of TRA-8 Anti-DR5 Monoclonal Antibody Alone or in Combination with Chemotherapy and/or Radiation Therapy in a Human Breast Cancer Model

Donald J. Buchsbaum, Tong Zhou, William E. Grizzle, Patsy G. Oliver, Charlotte J. Hammond, Sijian Zhang, Mark Carpenter, Albert F. LoBuglio
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (10): 3731–3741.
Published: 23 September 2003
View articletitled, Antitumor Efficacy of TRA-8 Anti-DR5 Monoclonal Antibody Alone or in Combination with Chemotherapy and/or Radiation Therapy in a Human Breast Cancer Model
Open the PDF for Antitumor Efficacy of TRA-8 Anti-DR5 Monoclonal Antibody Alone or in Combination with Chemotherapy and/or Radiation Therapy in a Human Breast Cancer Model in another window
Journal Articles

Selectivity of TAG-72-targeted Adenovirus Gene Transfer to Primary Ovarian Carcinoma Cells versus Autologous Mesothelial Cells in Vitro

F. Joseph Kelly, C. Ryan Miller, Donald J. Buchsbaum, Jesus Gomez-Navarro, Mack N. Barnes, Ronald D. Alvarez, David T. Curiel
Journal: Clinical Cancer Research
Clin Cancer Res (2000) 6 (11): 4323–4333.
Published: 01 November 2000
View articletitled, Selectivity of TAG-72-targeted Adenovirus Gene Transfer to Primary Ovarian Carcinoma Cells versus Autologous Mesothelial Cells in Vitro
Open the PDF for Selectivity of TAG-72-targeted Adenovirus Gene Transfer to Primary Ovarian Carcinoma Cells versus Autologous Mesothelial Cells in Vitro in another window
Journal Articles

Targeting Strategies for Cancer Radiotherapy

Donald J. Buchsbaum, Buck E. Rogers, M. B. Khazaeli, Matthew S. Mayo, Diane E. Milenic, S. V. S. Kashmiri, Carolyn J. Anderson, Lara L. Chappell, Martin W. Brechbiel, David T. Curiel
Journal: Clinical Cancer Research
Clin Cancer Res (1999) 5 (10): 3048s–3055s.
Published: 01 October 1999
View articletitled, Targeting Strategies for Cancer Radiotherapy
Open the PDF for Targeting Strategies for Cancer Radiotherapy in another window
Journal Articles

Comparison of Multiple Bolus and Continuous Injections of 131I-labeled CC49 for Therapy in a Colon Cancer Xenograft Model

Donald J. Buchsbaum, M. B. Khazaeli, Matthew S. Mayo, Peter L. Roberson
Journal: Clinical Cancer Research
Clin Cancer Res (1999) 5 (10): 3153s–3159s.
Published: 01 October 1999
View articletitled, Comparison of Multiple Bolus and Continuous Injections of 131I-labeled CC49 for Therapy in a Colon Cancer Xenograft Model
Open the PDF for Comparison of Multiple Bolus and Continuous Injections of 131I-labeled CC49 for Therapy in a Colon Cancer Xenograft Model in another window
Journal Articles

Biodistribution Study of 188Re-Labeled Trisuccin-HuCC49 and Trisuccin-HuCC49ΔCh2 Conjugates in Athymic Nude Mice Bearing Intraperitoneal Colon Cancer Xenografts1

Ahmad Safavy, M. B. Khazaeli, Kamellia Safavy, Matthew S. Mayo, Donald J. Buchsbaum
Journal: Clinical Cancer Research
Clin Cancer Res (1999) 5 (10): 2994s–3000s.
Published: 01 October 1999
View articletitled, Biodistribution Study of 188Re-Labeled Trisuccin-HuCC49 and Trisuccin-HuCC49ΔCh2 Conjugates in Athymic Nude Mice Bearing Intraperitoneal Colon Cancer Xenografts1
Open the PDF for Biodistribution Study of 188Re-Labeled Trisuccin-HuCC49 and Trisuccin-HuCC49ΔCh2 Conjugates in Athymic Nude Mice Bearing Intraperitoneal Colon Cancer Xenografts1 in another window
Journal Articles

In Vivo Localization of [111In]-DTPA-d-Phe1-Octreotide to Human Ovarian Tumor Xenografts Induced to Express the Somatostatin Receptor Subtype 2 Using an Adenoviral Vector1

Buck E. Rogers, Stephanie F. McLean, Richard L. Kirkman, Debbie Della Manna, Sheila J. Bright, Christine C. Olsen, Angela D. Myracle, Matthew S. Mayo, David T. Curiel, Donald J. Buchsbaum
Journal: Clinical Cancer Research
Clin Cancer Res (1999) 5 (2): 383–393.
Published: 01 February 1999
View articletitled, In Vivo Localization of [111In]-DTPA-d-Phe1-Octreotide to Human Ovarian Tumor Xenografts Induced to Express the Somatostatin Receptor Subtype 2 Using an Adenoviral Vector1
Open the PDF for In Vivo Localization of [111In]-DTPA-d-Phe1-Octreotide to Human Ovarian Tumor Xenografts Induced to Express the Somatostatin Receptor Subtype 2 Using an Adenoviral Vector1 in another window